Clinicopathological significance of human apurinic/apyrimidinic endonuclease 1 (APE1) expression in oestrogen-receptor-positive breast cancer Tarek M. A. Abdel-FatahChristina PerrySrinivasan Madhusudan Preclinical Study 01 January 2014 Pages: 411 - 421
Progesterone stimulates progenitor cells in normal human breast and breast cancer cells Heidi N. HiltonN. SantucciC. L. Clarke Preclinical study 07 January 2014 Pages: 423 - 433
Inhibition of FGFR signaling by PD173074 improves antitumor immunity and impairs breast cancer metastasis Tinghong YeXiawei WeiYuquan Wei Preclinical study 08 January 2014 Pages: 435 - 446
Clinical significance of CYLD downregulation in breast cancer Mitsuhiro HayashiHirofumi JonoYukio Ando Preclinical study 08 January 2014 Pages: 447 - 457
Everolimus plus exemestane as first-line therapy in HR+, HER2− advanced breast cancer in BOLERO-2 J. Thaddeus BeckGabriel N. HortobagyiMartine Piccart Clinical Trial Open access 21 December 2013 Pages: 459 - 467
The impact of the pathological lymph node status on adjuvant systemic treatment recommendations in clinically node negative breast cancer patients L. M. van RoozendaalR. J. SchipperM. L. Smidt Clinical Trial 04 January 2014 Pages: 469 - 476
Tamoxifen dose and serum concentrations of tamoxifen and six of its metabolites in routine clinical outpatient care N. G. L. JagerH. RosingJ. H. Beijnen Clinical trial 05 January 2014 Pages: 477 - 483
Central pathology laboratory review of HER2 and ER in early breast cancer: an ALTTO trial [BIG 2-06/NCCTG N063D (Alliance)] ring study Ann E. McCulloughPatrizia Dell’OrtoGiuseppe Viale Clinical trial 07 January 2014 Pages: 485 - 492
A phase II, randomized, multicenter study evaluating the combination of lapatinib and vinorelbine in women with ErbB2 overexpressing metastatic breast cancer Wolfgang JanniTomasz SarosiekChristos Papadimitriou Clinical trial Open access 09 January 2014 Pages: 493 - 505
Prospective evaluation of the conversion rate in the receptor status between primary breast cancer and metastasis: results from the GEICAM 2009-03 ConvertHER study Eduardo Martínez de DueñasAna Lluch HernándezAna María González-Angulo Clinical trial Open access 11 January 2014 Pages: 507 - 515
Circulating estrogens and estrogens within the breast among postmenopausal BRCA1/2 mutation carriers Jennifer T. LoudGretchen L. GierachMitchell H. Gail Clinical Trial 18 January 2014 Pages: 517 - 529
Utility of 3-dimensional echocardiography, global longitudinal strain, and exercise stress echocardiography to detect cardiac dysfunction in breast cancer patients treated with doxorubicin-containing adjuvant therapy Michel G. KhouriWhitney E. HornsbyLee W. Jones Epidemiology 04 January 2014 Pages: 531 - 539
Factors associated with long-term adherence to annual surveillance mammography among breast cancer survivors Heidi S. WirtzDenise M. BoudreauDiana S. M. Buist Epidemiology 10 January 2014 Pages: 541 - 550
Treatment and outcomes in diabetic breast cancer patients Heather Taffet GoldNour MakaremNiyati Parekh Epidemiology 18 January 2014 Pages: 551 - 570
Patterns of nodal staging during breast conservation surgery in the medicare patient: will the ACOSOG Z0011 trial change the pattern of care? Catherine E. Loveland-JonesKaren RuthRichard J. Bleicher Epidemiology 19 January 2014 Pages: 571 - 577
Timing of oral contraceptive use and the risk of breast cancer in BRCA1 mutation carriers Joanne KotsopoulosJan LubinskiHereditary Breast Cancer Clinical Study Group Epidemiology 24 January 2014 Pages: 579 - 586
Long-term impact of the 70-gene signature on breast cancer outcome C. A. DrukkerH. van TinterenL. J. van’t Veer Brief Report Open access 21 January 2014 Pages: 587 - 592
Context-dependent role of Grb7 in HER2+ve and triple-negative breast cancer cell lines Reece C. C. LimJohn T. PriceJacqueline A. Wilce Brief Report 25 January 2014 Pages: 593 - 603
Steroid hormone receptor expression in breast cancer stroma Mary E. BoothAndrew M. HanbyValerie Speirs Letter to the Editor 24 January 2014 Pages: 605 - 607
Estrogen receptor status of breast stromal cells Kevin C. KnowerAshwini L. ChandColin D. Clyne Rebuttal Letter 25 January 2014 Pages: 609 - 610